Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $441.56 | 9 | 78.8% |
| Travel and Lodging | $108.50 | 1 | 19.4% |
| Education | $10.24 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $202.33 | 6 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $112.47 | 1 | $0 (2017) |
| Stryker Corporation | $108.50 | 1 | $0 (2020) |
| AbbVie Inc. | $101.60 | 1 | $0 (2021) |
| Davol Inc. | $22.23 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $13.17 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $123.83 | 2 | AbbVie Inc. ($101.60) |
| 2020 | $108.50 | 1 | Stryker Corporation ($108.50) |
| 2019 | $67.60 | 1 | Amarin Pharma Inc. ($67.60) |
| 2018 | $13.17 | 1 | Novartis Pharmaceuticals Corporation ($13.17) |
| 2017 | $247.20 | 6 | Amarin Pharma Inc. ($134.73) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/03/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $101.60 | General |
| 04/10/2021 | Davol Inc. | — | Food and Beverage | In-kind items and services | $22.23 | General |
| 03/14/2020 | Stryker Corporation | MAKO (Device) | Travel and Lodging | Cash or cash equivalent | $108.50 | General |
| Category: KNEES, HIPS | ||||||
| 10/23/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $67.60 | General |
| Category: Hypertriglyceridemia | ||||||
| 07/26/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/09/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/23/2017 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | In-kind items and services | $112.47 | General |
| Category: Cardiology | ||||||
| 08/02/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: Hypertriglyceridemia | ||||||
| 05/01/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Hypertriglyceridemia | ||||||
| 03/29/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $113.84 | General |
| Category: Hypertriglyceridemia | ||||||
| 03/29/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.24 | General |
| Category: Hypertriglyceridemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 128 | 3,167 | $313,477 | $144,424 |
| 2020 | 7 | 213 | 1,346 | $97,075 | $66,700 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 98927 | Osteopathic manipulative treatment to 5-6 body regions | Office | 2021 | 50 | 1,412 | $204,752 | $71,310 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 1,078 | $80,850 | $63,747 | 78.8% |
| 97012 | Application of mechanical traction to 1 or more areas | Office | 2021 | 14 | 435 | $21,825 | $5,609 | 25.7% |
| 36410 | Insertion of needle into vein, patient 3 years or older | Office | 2021 | 22 | 242 | $6,050 | $3,759 | 62.1% |
| 98927 | Osteopathic manipulative treatment to 5-6 body regions | Office | 2020 | 62 | 500 | $37,500 | $24,925 | 66.5% |
| 99348 | Established patient home visit, typically 25 minutes | Office | 2020 | 23 | 262 | $24,790 | $18,307 | 73.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 236 | $17,700 | $13,260 | 74.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 66 | $5,610 | $4,408 | 78.6% |
| 36410 | Insertion of needle into vein, patient 3 years or older | Office | 2020 | 47 | 180 | $4,500 | $2,613 | 58.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 15 | $2,625 | $2,064 | 78.6% |
| 97012 | Application of mechanical traction to 1 or more areas | Office | 2020 | 18 | 87 | $4,350 | $1,124 | 25.8% |
About Dr. Anthony Villare, MD
Dr. Anthony Villare, MD is a Family Medicine healthcare provider based in Paulsboro, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114954054.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Villare, MD has received a total of $560.30 in payments from pharmaceutical and medical device companies, with $123.83 received in 2021. These payments were reported across 11 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($441.56).
As a Medicare-enrolled provider, Villare has provided services to 341 Medicare beneficiaries, totaling 4,513 services with total Medicare billing of $211,124. Data is available for 2 years (2020–2021), covering 11 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Paulsboro, NJ
- Active Since 06/27/2006
- Last Updated 09/30/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114954054
Products in Payments
- Vascepa (Drug) $202.33
- Livalo (Drug) $112.47
- MAKO (Device) $108.50
- ENTRESTO (Drug) $13.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.